R&D Advances in immunosuppression research may bring transplant ... There has been little innovation in immunosuppression therapy for organ transplant patients over the past 30 years.
Partner Content Partner Content Only four weeks till SMi’s 3D Cell Culture Conference 2019 Only four weeks till SMi’s 3D Cell Culture
News In shock move, EU panel rejects Alzheimer's drug Leqembi The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh
Sales & Marketing Sponsored How doctors are interacting with content in 10 data trends It will come as no surprise to anyone in the healthcare space that doctors today are under an inordinate amount of pressure.